Mixed venous oxygen saturation is a prognostic marker after surgery for aortic stenosis.
BACKGROUND
Adequate monitoring of the hemodynamic state is essential after cardiac surgery and is vital for medical decision making, particularly concerning hemodynamic management. Unfortunately, commonly used methods to assess the hemodynamic state are not well documented with regard to outcome. Mixed venous oxygen saturation (SvO(2)) was therefore investigated after cardiac surgery.


METHODS
Detailed data regarding mortality were available on all patients undergoing aortic valve replacement for isolated aortic stenosis during a 5-year period in the southeast region of Sweden (n=396). SvO(2) was routinely measured on admission to the intensive care unit (ICU) and registered in a database. A receiver operating characteristics (ROC) analysis of SvO(2) in relation to post-operative mortality related to cardiac failure and all-cause mortality within 30 days was performed.


RESULTS
The area under the curve (AUC) was 0.97 (95% CI 0.96-1.00) for mortality related to cardiac failure (P=0.001) and 0.76 (95% CI 0.53-0.99) for all-cause mortality (P=0.011). The best cutoff for mortality related to cardiac failure was SvO(2) 53.7%, with a sensitivity of 1.00 and a specificity of 0.94. The negative predictive value was 100%. The best cutoff for all-cause mortality was SvO(2) 58.1%, with a sensitivity of 0.75 and a specificity of 0.84. The negative predictive value was 99.4%. Post-operative morbidity was also markedly increased in patients with a low SvO(2).


CONCLUSIONS
SvO(2), on admission to the ICU after surgery for aortic stenosis, demonstrated excellent sensitivity and specificity for post-operative mortality related to cardiac failure and a fairly good AUC for all-cause mortality, with an excellent negative predictive value.
Holm
J
J
Department of Cardiothoracic Surgery and Anesthesia, University Hospital, Linköping University, Linköping, Sweden.
Håkanson
R E
RE
Vánky
F
F
Svedjeholm
R
R
D000368:Aged; D001024:Aortic Valve Stenosis / Q000097:blood* / Q000401:mortality / Q000601:surgery*; D002316:Cardiotonic Agents / Q000008:administration & dosage; D002407:Catheterization, Swan-Ganz; D015331:Cohort Studies; D005260:Female; D006333:Heart Failure / Q000401:mortality*; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D010100:Oxygen / Q000097:blood*; D011183:Postoperative Complications / Q000401:mortality*; D011237:Predictive Value of Tests; D011379:Prognosis; D012372:ROC Curve; D012016:Reference Values; D013548:Sweden / Q000453:epidemiology; D014680:Veins
D002316:Cardiotonic Agents; D010100:Oxygen